Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Operating Leases (2019 - 2026)

Natural Health Trends (NHTC) has disclosed Operating Leases for 8 consecutive years, with $2.1 million as the latest value for Q1 2026.

  • For Q1 2026, Operating Leases fell 8.1% year-over-year to $2.1 million; the TTM value through Mar 2026 reached $2.1 million, down 8.1%, while the annual FY2025 figure was $1.1 million, 25.3% down from the prior year.
  • Operating Leases hit $2.1 million in Q1 2026 for Natural Health Trends, up from $1.1 million in the prior quarter.
  • Across five years, Operating Leases topped out at $4.0 million in Q1 2023 and bottomed at $1.1 million in Q4 2025.
  • Average Operating Leases over 5 years is $2.5 million, with a median of $2.3 million recorded in 2023.
  • Year-over-year, Operating Leases surged 55.03% in 2022 and then tumbled 46.75% in 2024.
  • Natural Health Trends' Operating Leases stood at $3.0 million in 2022, then decreased by 22.45% to $2.3 million in 2023, then tumbled by 34.69% to $1.5 million in 2024, then dropped by 25.3% to $1.1 million in 2025, then soared by 82.49% to $2.1 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods came in at $2.1 million, $1.1 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.